← All trials
NCT00708799
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2007
- Primary completion
- Nov 30, 2013
- Completion date
- Nov 30, 2013
- First posted
- Jul 2, 2008
- Last posted
- Apr 21, 2017
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Department of Veteran AffairsLead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- Northwestern UniversityCollaborator
- South Texas Health Care System, San Antonio, TXOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.